Latest filing published 03 Apr 2018 for MABVAX THERAPEUTICS HOLDINGS, INC.. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Gregory P. Hanson on record concern Mabvax Therapeutics Holdings, Inc. Between 4 April 2016 and 2 April 2018, the trades on record add up to 20 filings.
On the open market, the record shows 3 purchases worth €6,749 and 11 sales worth €142k. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 4 option exercises. So far in 2018, the count stands at no purchases and 4 sales.
On 3 April 2018 came the latest disclosure, an option exercise in Mabvax Therapeutics Holdings, Inc. The most recent open-market purchase was published on 2 August 2017, 3,366 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations